Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (6)
  • 2024 (4)
  • 2023 (15)
  • 2022 (9)
  • 2021 (15)

Subject

  • Drug Trafficking (500)
  • Synthetic drugs (251)
  • Seizures (Drugs/Property) (206)
  • Task Forces/Task Force Officers (169)
  • Major Law Enforcement Operation (135)
  • OCDETF/Task Force (119)
  • Guns/Weapons (106)
  • Fake Pills (88)
  • Overdose (74)
  • Arrests/Convictions - Major (72)
  • Gangs (57)
  • Prescription Drugs (57)
  • Guilty Plea (53)
  • Pharmaceuticals/Pharmacists/Physicians (42)
  • One Pill Can Kill (40)
  • Narcoterrorism (39)
  • Fentanyl Awareness (37)
  • Money Laundering (34)
  • Outreach/Drug Prevention (29)
  • Press Conferences (23)
  • Take Back Day (14)
  • HIDTA (10)
  • Public and Media Affairs - also see Congressional Affairs (9)
  • Dark Web- Internet Trafficking (7)
  • Extraditions (7)
  • Fentanyl Free America (7)
  • International/Foreign Operations (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Asset Forfeiture (5)
  • Counterfeit Pills (2)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Terrorism (2)
  • Campaigns (1)
  • Cartel (1)
  • Congressional Affairs (1)
  • Intelligence Division - Intelligence Products (1)
  • Diversion Division (50)

Drug Name

  • Opioids (22)
  • Oxycodone (12)
  • Synthetic Opioids (9)
  • Fentanyl (6)
  • Hydromorphone (4)
  • Benzodiazepines (3)
  • Steroids (3)
  • Morphine (2)
  • Methadone (1)

Field Division

  • New England (35)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • El Paso (8)
  • New Orleans (8)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • Washington, DC (34)
  • Houston (16)
Clear All Results
50 Results - Showing 1 to 10
PRESS RELEASE

Laredo Pharmacist Pays Six Figures to Settle Controlled Substance Act Violations

HOUSTON – The owner of Martinez Pharmacy in Laredo has agreed to pay $750,000 to resolve allegations his pharmacy violated federal recordkeeping and dispensing requirements, announced Drug Enforcement Administration (DEA) Special Agent in Charge Miguel Madrigal of the San Antonio Division and U.S. Attorney Nicholas J. Ganjei. Antonio Martinez Jr...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

Washington, DC – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
PRESS RELEASE

2025 National Health Care Fraud Takedown

ALEXANDRIA, Va. – Erik S. Siebert, U.S. Attorney for the Eastern District of Virginia, announced criminal charges against six defendants. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown . The charges are part of a strategically coordinated, nationwide law...
PRESS RELEASE

Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice

WASHINGTON -- Ndubuisi Joseph Okafor, M.D., 65, of Upper Marlboro, Maryland, was sentenced today in U.S. District Court to 18 years in prison for illegally distributing prescriptions for narcotics in exchange for cash from his Northwest Washington D.C. medical clinic. A jury found Okafor guilty on Mar. 21, 2025, of...
PRESS RELEASE

DEA Safely Disposes 620,000 Pounds of Unused Medication on 28th National Prescription Drug Take Back Day

WASHINGTON D.C. – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Locally, the...
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
PRESS RELEASE

San Antonio Man Sentenced to 28 Years in Federal Prison for Armed Pharmacy Robberies

SAN ANTONIO – A San Antonio man was sentenced to 339 months in federal prison for three counts of pharmacy robbery and three counts of brandishing a firearm during and in relation to a crime of violence. According to court documents, from October to December 2020, Atseko Factor, 40, and...
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster